Medicine and Dentistry
Malignant Neoplasm
100%
Patient-Reported Outcome
72%
Quality of Life
45%
Oncology
28%
Clinical Trial
27%
Neoplasm
22%
Diseases
21%
Breast Cancer
21%
Cancer Therapy
17%
Radiation Therapy
17%
Chronic Pain
15%
Head and Neck Cancer
15%
Cancer-Related Fatigue
14%
Multiple Myeloma
14%
Lung Cancer
13%
Odds Ratio
13%
Adverse Event
13%
Neuropathic Pain
12%
Randomized Controlled Trial
12%
Clinician
12%
Oropharynx Carcinoma
12%
Brief Pain Inventory
11%
Cancer Treatment
11%
In Vitro
11%
Macrophage
11%
Cancer Pain
11%
Analgesia
10%
Systematic Review
10%
Meta-Analysis
10%
Symptom Assessment
9%
Intensity Modulated Radiation Therapy
9%
Metastatic Carcinoma
9%
Advanced Cancer
8%
Neck
8%
Solid Malignant Neoplasm
8%
Symptom Management
8%
Immune System
7%
T Cell
7%
Cytokine
7%
Dexamethasone
7%
Outcome Assessment
7%
Non Small Cell Lung Cancer
7%
Lung
7%
Endorphin
7%
Chemoradiotherapy
7%
Neuropathy
7%
Cancer
7%
Intracranial Tumor
7%
Recurrent Disease
7%
Symptomatic Treatment
6%
Overall Survival
6%
Systemic Therapy
6%
Chemotherapy-Induced Peripheral Neuropathy
6%
Arm
6%
COVID-19
6%
Interleukin 10
6%
Secretion (Process)
6%
Pain Assessment
6%
Lymphocyte
6%
Immunity
6%
Logistic Regression Analysis
6%
Interleukin 6
6%
Bone Metastasis
5%
Magnetic Resonance Imaging
5%
Anemia
5%
Health Care
5%
Perioperative Period
5%
Colorectal Carcinoma
5%
Placebo
5%
Hyperpathia
5%
Biopsy Technique
5%
Paresthesia
5%
Hydrocortisone
5%
Prevalence
5%
Observational Study
5%
Self Report
5%
Cancer Diagnosis
5%
Dorsal Root Ganglion
5%
Neuroscience
Behavior (Neuroscience)
36%
Ischemia
20%
Cisplatin
19%
Neuropathic Pain
18%
T Cell
17%
Brain Injury
15%
Receptor
15%
Neuropathy
14%
Cognitive Disorder
14%
Mesenchymal Stem Cell
14%
Macrophage
14%
Kynurenine
14%
Cortisol
13%
Microglia
13%
Lipopolysaccharide
13%
Nerve Injury
11%
Interleukin 10
11%
Longitudinal Study
11%
In Vitro
11%
Stem Cell
10%
Dexamethasone
10%
Intracranial Tumor
9%
Allodynia
9%
Glucocorticoid
9%
Interleukin 6
9%
Dorsal Root Ganglion
9%
Metabolic Pathway
9%
Kinase
9%
Peripheral Blood Mononuclear Cell
8%
Central Nervous System
8%
Hyperalgesia
8%
Radiation Therapy
8%
Anti-Inflammatory
8%
G Protein Coupled Receptor Kinase 2
8%
Leukocyte
7%
Adrenergic Receptor
7%
Depressive Disorder
7%
Blood Plasma
7%
Sensory Neuron
7%
Hippocampus
7%
Gene Expression
7%
Sickness Behavior
7%
Interleukin 1
6%
In Vivo
6%
Posttraumatic Stress Disorder
6%
G Protein Coupled Receptor
6%
Neuroprotection
6%
Paclitaxel
6%
Proinflammatory Cytokine
6%
Messenger RNA
6%
Comorbidity
6%
Hematopoietic Cell
5%
Neuroprotective Agent
5%
Chronic Fatigue Syndrome
5%
Meta-Analysis
5%
Astrocyte
5%
Kynurenic Acid
5%
Sleep Disorder
5%
Cyclic Adenosine Monophosphate
5%
Cytokine Production
5%
Mood Disorder
5%
Endorphin
5%
Natural Killer Cell
5%
Neuroscience
5%
Major Depressive Disorder
5%
NMDA Receptor
5%
Keyphrases
Symptom Burden
35%
MD Anderson Symptom Inventory (MDASI)
35%
Patient-reported Outcomes
31%
Cancer Patients
26%
Inflammation
17%
In Cancer
16%
T Cells
14%
GRK2
13%
Quality of Life
13%
Patient-Reported Outcomes Measurement Information System (PROMIS)
12%
Head-and-neck Cancer
12%
Immune System
11%
Chronic Pain
11%
Cancer Treatment
11%
Hypoxia-ischemia
11%
Chemotherapy-induced Peripheral Neuropathy
10%
Patient-reported Symptoms
10%
Symptom Assessment
9%
Neuropathic Pain
9%
Symptom Severity
9%
Interleukin-1β
8%
Health-related Quality of Life
8%
Tumor
8%
Confidence Interval
7%
Lung Cancer
7%
Cancer Survivors
7%
Peripheral Blood Mononuclear Cells
7%
Multiple Myeloma
7%
Meta-analysis
7%
Patients with Cancer
7%
Symptom Interference
7%
Head-and-neck
7%
Interleukin-10
6%
Clinical Trials
6%
Oropharyngeal Squamous Cell Carcinoma (OPSCC)
6%
Macrophages
6%
Cancer Therapy
6%
Brief Fatigue Inventory
6%
Odds Ratio
6%
Cancer-related Symptoms
6%
Cisplatin
6%
Radiation Therapy
6%
Non-small Cell Lung Cancer (NSCLC)
6%
Interleukin-6
6%
Severe Symptoms
6%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
5%
β-endorphin
5%
Chemotherapy
5%
Lipopolysaccharide
5%
Minocycline
5%
Dorsal Root Ganglion
5%
Paclitaxel
5%
Immune Response
5%
Breast Cancer Patients
5%
Cancer Pain
5%
Indoleamine 2,3-dioxygenase 1 (IDO1)
5%
Brain Tumor
5%
Mechanical Allodynia
5%
Solid Tumors
5%
Brief Pain Inventory
5%